Acoustic neuroma (Vestibular Schwannoma)

Acoustic neuroma (also known as a vestibular schwannoma) is a low grade brain tumour accounting for 8% of all primary brain tumours. They tend to affect adults between the ages of 30 to 60. Vestibular schwannomas are slow growing and are rarely life threatening.

This type of tumour grows along the eighth cranial nerve in the brain, also known as the acoustic or vestibulocochlear nerve. As the nerve controls hearing and balance, loss of hearing in one ear, or problems with balance, are common symptoms. The tumour arises from a type of cell called a schwann cell. Schwann cells wrap themselves around nerves to protect them and support their function.

What are the symptoms?

Vestibular schwannomas can sometimes be difficult to diagnose and their symptoms can be similar to other conditions such as Ménière's disease, a condition that affects the inner ear causing progressive deafness and attacks of tinnitus and vertigo.

Key symptoms include:

  • hearing loss - the first symptom in 90% of patients is a reduction in hearing in one ear, often accompanied by ringing in the ear called tinnitus. This usually progresses with time, although some patients may experience a sudden loss of hearing. Some people also experience a feeling of 'fullness' in the affected ear. Diagnosis can often be delayed as this can be misdiagnosed as age-related hearing loss or exposure to high levels of noise earlier in life.
  • vertigo (sensation of your surroundings spinning) - unsteadiness and balance problems may occur during the growth of the tumour. This is due to the location of where the tumour arises on the eighth cranial nerve.

Larger tumours may lead to increased pressure in the brain, in turn causing headaches and blurred or double vision. If the tumour presses on the facial nerve (trigeminal nerve), it can cause facial numbness and tingling. Even with treatment, symptoms such as tinnitus and hearing loss can persist. These symptoms will require additional treatment.

How is a vestibular schwannoma diagnosed?

If you have a suspected vestibular schwannoma, your doctors need to find out as much as possible about the position and size of your tumour so they can plan your treatment. Routine auditory tests may reveal a loss of hearing and speech decline. An audiogram will be performed to evaluate the level of hearing in both ears and sometimes a test is done to check your sense of balance. The doctor will also test your reflexes and the strength in your arms and legs. If there is a noticeable loss of hearing in one ear, a Magnetic Resonance Imaging (MRI) scan will be performed.

Magnetic resonance imaging (MRI) is the preferred diagnostic test to identify these tumour times. If you are having an MRI scan, you will be asked if you have a pacemaker, any implants, such as a programmable shunt or skull section, or if you are likely to have any metal in your body due to working in the steel or metal industries. If you have, then an MRI may not be suitable for you as it uses magnetic fields to take images. Your radiographer will be able to tell you more.

When an MRI cannot be performed, a computerized tomography (CT) scan with contrast is suggested.

How is a vestibular schwannoma treated?

When you are diagnosed, the most appropriate treatment for you can depend on a number of factors. Things that your medical team will consider when deciding what treatment is right for you can include:

  • the size of the tumour
  • how the symptoms are affecting you
  • your general health

Generally, the treatment approaches taken include 'watch and wait', surgery or stereotactic radiotherapy.

Watch and wait

Some vestibular schwannomas may not need immediate treatment. This is usually when they are small and not causing symptoms. If on 'watch and wait', you will see your specialist for regular check ups/MRI scans every 3, 6 or 12 months. You might begin treatment if:

  • there is a marked increase in tumour size
  • you develop symptoms, or worsening of symptoms, that badly affect your quality of life - for example, uncontrollable seizures
  • the tumour becomes a higher grade

Depending on your tumour and age, this could take many years, or not happen at all.


Surgery is usually only used to remove larger tumours as it can result in the loss of hearing in the affected ear. Your surgeon will explain what is involved in the procedure and potential risks and complications. The surgeon may leave a small part of the tumour to prevent damage to the facial nerve. Any tumour cells that are left behind can be treated with stereotactic radiosurgery.

You may wish to discuss the possibility of having a 'bone anchored hearing aid' with your surgeon. This diverts sound from your affected ear to your good ear. Occasionally surgery can result in damage to the facial nerve, causing your face to droop on one side or difficulty in closing that eye.

Stereotactic radiotherapy

Smaller tumours or parts of a tumour that were unable to be removed by surgery may be treated with stereotactic radiotherapy (SRT). This treatment uses X-ray beams to more accurately target the tumour from different angles. The beams intersect at the tumour site, maximising the dose of radiation there and destroying tumour cells. SRT can be given over multiple sessions (fractionated stereotactic radiotherapy or FSRT), or it can be given in one session (stereotactic radiosurgery or SRS). SRS does not involve actual surgery. Not all brain tumours are suitable to be treated with SRT or SRS - conventional radiotherapy is more appropriate in some cases.

Neurofibromatosis type 2

The cause of vestibular schwannomas is unknown, however around 7% of cases are caused by a rare genetic disorder known as Neurofibromatosis type 2 (NF-2). This type of genetic condition causes low grade tumours to grow along your nerves. NF-2 is caused by a permanent change, or gene mutation, in the DNA sequence that makes up a gene. This in turn means that the growth of nerve tissue can become uncontrolled. In half of all cases of NF-2, the mutation is passed on from one generation the other. i.e. parent to child. Although there are genetic tests that can be carried out during pregnancy to test whether your child will have NF-2, it is normally diagnosed after birth.

Did you find this information useful?

Please rate the information on this page:

How can we make this page better?

If you have further questions, need to clarify any of the information on this page, or want to find out more about research and clinical trials, please contact our team:

Support & Info Line

0808 800 0004 (free from landlines and mobiles)

Research & Clinical Trials Info Line

01252 749 999

Phone lines open Mon-Fri, 09:00-17:00

You can also join our active online community on Facebook - find out more about our groups.